All New DNA Body Blueprint Provides Integrated
Personal Action Plan Focusing on Genetic-Based Eating Behaviors,
Nutrition and Metabolism
Simple, Effective and Secure At-Home DNA Test
is Supported by Science and Comprehensively Developed to Help
Weight Loss and Weight Management
Nutrisystem, Inc. (Nasdaq: NTRI), a leading provider
of health and wellness and weight management products and
services including Nutrisystem® and South Beach Diet®
brands, today announced the launch of DNA Body Blueprint™, a
genetic-based product using a proprietary algorithm that provides
an integrated personal action plan focused on eating behaviors,
nutrition and metabolism. The national marketing campaign will
debut this week.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20180716005351/en/
Nutrisystem announces the launch of DNA
Body Blueprint™, a genetic-based product using a proprietary
algorithm that provides an integrated personal action plan focused
on eating behaviors, nutrition and metabolism. (Photo: Business
Wire)
“By providing a personalized overview that is the ultimate
roadmap for an individual’s ongoing nutritional needs, this product
delivers on our mission of helping consumers make more informed
choices and achieve outcomes that drive overall health,” commented
Dawn Zier, President and CEO, Nutrisystem, Inc. “This
groundbreaking use of DNA technology is a major step forward in the
areas of weight loss, maintenance, and personalized nutrition.
Consumer interest is high and we believe this product will attract
new consumers to our brand as well as allow us to extend our
relationship with them as they transition from weight loss to an
ongoing healthy lifestyle.”
Years of Development Leads to National Debut
As a leader with a history in innovative and
scientifically-backed weight loss solutions, Nutrisystem
greenlighted the creation of DNA Body Blueprint based on a thorough
assessment of market dynamics and scientific reviews from its
Science Advisory Board. The board consists of a team of renowned
professionals, each with distinct backgrounds and expertise, who
helped evaluate existing research to enhance current programs, as
well as develop new programs utilizing the latest science and
technology trends within weight management.
The Company worked closely with and entered into an exclusive
agreement with Genetic Direction, a leading provider of
DNA-based health management programs, to develop a simple and
secure DNA test that uses advanced genetic testing technology and
genomic analysis to create an innovative and comprehensive product
in the weight loss and weight management space. Proprietary
algorithms were designed to accurately analyze genetic variants
known as single nucleotide polymorphisms (SNPs) that may affect
absorption and uptake of nutrients, processing of nutrients,
metabolism, behaviors and optimal fitness approaches. For example,
customers will discover whether they are more genetically inclined
to lose weight and maintain weight loss, whether they have a slower
or faster metabolism, and how their body processes macronutrients
such as carbohydrates, fats and proteins, and what to do about it.
Customers will be able to discuss their personalized report with a
weight loss counselor and tailor their program based on the report
findings.
“Nutrisystem, along with our Science Advisory Board, has had an
eye on this space over the last few years and is pleased to see the
technology safely and constructively evolve,” said David Burton,
Executive Vice President of Operations at Nutrisystem, Inc. “Our
mission is to match the most cutting-edge scientific developments
with proven nutritional data to give our customers the best weight
management experience possible, and we’re pleased to bring this to
market after having worked extensively on this initiative for the
last 24 months. We did an exhaustive search for the right partners
and are proud to be rolling out a high-caliber offering at scale
with unprecedented personalization.”
Dr. Tim Church, Medical Director, Genetic Direction, a
distinguished researcher and specialist in public health and
general preventive medicine and one of the country’s leading
physicians in exercise and obesity research, echoed this sentiment,
saying, “We’ve worked for many years to refine the science behind
DNA testing as it relates to health and wellness. We now have a
product that can make a difference in peoples’ lives and by working
with Nutrisystem, together we can raise broad awareness and prompt
mainstream adoption.”
Nutrisystem, through Genetic Direction, will be utilizing
AKESOgen, an industry leading global genetic testing lab, to
provide data and results using the most secure data encryption
technology available, including de-identified samples and barcode
matching.
Dr. Mark Bouzyk, Chief Scientific Officer, AKESOgen, who has
been a global scientific leader in the precision genetics space
over the last two decades commented, “The time is right to leverage
the most robust and exciting scientific discoveries over the last
several years in the public health and wellness continuum to
benefit the community at large. This comes at a time of
unprecedented cost benefits in genetic technologies that is
coincidentally timely for the consumer market. Coupling this with
Nutrisystem’s vision is absolutely a win-win for all.”
National Advertising & Marketing Campaign
DNA Body Blueprint is slated to be prominently featured in
national multi-media marketing and advertising campaigns debuting
today, July 16.
“We are thrilled to introduce our DNA-informed product
nationwide, via television, social, paid digital, and eCRM. Our DNA
Body Blueprint leverages what Nutrisystem does better than anyone.
We start with cutting edge science, then make it simple and easy to
understand. We’re excited to provide each customer with a blueprint
to lose weight successfully. It’s the healthy eating approach
designed by your body,” explained Keira Krausz, CMO, Nutrisystem,
Inc. “We worked closely with potential customers to develop both
the product and our campaign, and we know their ongoing insights
will play a pivotal role in how we continue to evolve the
offering.”
View one of the Body Blueprint DNA national television ads
here.
White Paper & Fact Sheet
The Science Behind Nutrisystem® DNA Body Blueprint™ White Paper
can be found here.Authors: LeeAnn Kindness, MS, Mandi Knowles,
RDN/LDN, Courtney McCormick, MPH, RDN/LDN, Noah Voreades, MS, Mark
Bouzyk, PhD, Dr. Mark SarzynskiReviewers: Gary Bennett, PhD., Ted
Kyle, RPh, MBA
Additional information on the Nutrisystem DNA Body Blueprint can
be found here along with a fact sheet, here.
About Nutrisystem, Inc.
Nutrisystem, Inc. (Nasdaq: NTRI) is a leader in the
weight-loss industry, having helped millions of people lose weight
over the course of more than 45 years. The Company’s multi-brand
approach to weight loss includes multiple plans for 2018. For more
information, go to NutrisystemNews.com and
Newsroom.SouthBeachDiet.com.
About Genetic Direction
Genetic Direction is a healthcare software company that improves
individuals’ lives by evaluating key genetic markers and developing
personalized health management programs in the areas of weight
management, healthy aging and peak athletic performance. Genetic
Direction’s proprietary algorithms and protocols utilize the latest
peer-reviewed genetic research and are delivered to consumers,
clients and patients through healthcare providers, retail marketing
partners and directly via its secure web platform and one-on-one
telehealth consultations.
About AKESOgen
AKESOgen is an integrated Clinical Laboratory Improvement
Amendments (CLIA) compliant and College of American Pathology (CAP)
accredited genomics, genetics and bio-banking company that services
the pharmaceutical, biotechnology, clinical, academic, and
government sectors for clinical trials, diagnostic clinical
testing, and research. Based in Atlanta, GA, USA, the company’s
main focus is oncology, neurology and personalized medicine.
AKESOgen’s services include providing high-throughput, biomarker
profiling, cytogenetic arrays, sequencing, and genomics analysis
utilizing different types of markers (e.g. DNA, mRNA, miRNA, and
methylation). For more information, visit www.akesogen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180716005351/en/
Nutrisystem, Inc.Robin McConnell ShallowSenior Vice President,
Corporate Communications and Public
Relations215-346-8068rshallow@nutrisystem.comorICR, Inc.John Mills,
Partner646-277-1254ir@nutrisystem.comJohn.Mills@Icrinc.com
Nutrisystem (NASDAQ:NTRI)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Nutrisystem (NASDAQ:NTRI)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024